BlackRock Inc. - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 64 filers reported holding ONCOCYTE CORP in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$278,766
-44.8%
1,212,026
-15.0%
0.00%
Q1 2023$505,157
+11.0%
1,425,386
+0.5%
0.00%
Q4 2022$455,168
-72.9%
1,418,408
-38.5%
0.00%
Q3 2022$1,682,000
-20.2%
2,305,331
-1.6%
0.00%
Q2 2022$2,108,000
-71.3%
2,343,426
-52.5%
0.00%
Q1 2022$7,351,000
-32.1%
4,933,649
-1.2%
0.00%
Q4 2021$10,834,000
-30.3%
4,993,146
+14.3%
0.00%
Q3 2021$15,552,000
-42.7%
4,368,736
-7.6%
0.00%
-100.0%
Q2 2021$27,149,000
+5.3%
4,729,726
-4.8%
0.00%0.0%
Q1 2021$25,784,000
+208.0%
4,968,214
+41.9%
0.00%
Q4 2020$8,371,000
+82.9%
3,502,031
+6.3%
0.00%
Q3 2020$4,577,000
-7.8%
3,293,383
+26.7%
0.00%
Q2 2020$4,964,000
+29.4%
2,598,615
+66.0%
0.00%
Q1 2020$3,835,000
+7.4%
1,565,566
-1.4%
0.00%
Q4 2019$3,571,000
+7.1%
1,587,005
-0.1%
0.00%
Q3 2019$3,335,000
-13.8%
1,588,066
+2.2%
0.00%
Q2 2019$3,869,000
+678.5%
1,553,990
+1136.2%
0.00%
Q1 2019$497,000
+446.2%
125,702
+90.0%
0.00%
Q4 2018$91,000
-45.2%
66,1460.0%0.00%
Q3 2018$166,000
-1.8%
66,1460.0%0.00%
Q2 2018$169,000
-60.8%
66,146
-67.8%
0.00%
Q1 2018$431,000
-55.3%
205,187
-1.0%
0.00%
Q4 2017$964,000
-32.8%
207,173
+9.1%
0.00%
Q3 2017$1,435,000
+39.7%
189,969
-3.9%
0.00%
Q2 2017$1,027,000
+111.8%
197,699
+142.6%
0.00%
Q1 2017$485,00081,507
+156644.2%
0.00%
Q1 2016$0520.00%
Other shareholders
ONCOCYTE CORP shareholders Q4 2020
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 14,716,204$20,456,0001.61%
PURA VIDA INVESTMENTS, LLC 6,022,534$8,371,0000.43%
P.A.W. CAPITAL CORP 199,700$278,0000.30%
Penbrook Management LLC 229,425$319,0000.28%
PERKINS CAPITAL MANAGEMENT INC 39,725$55,0000.05%
GSA CAPITAL PARTNERS LLP 201,047$279,0000.05%
Private Wealth Partners, LLC 150,000$209,0000.02%
Phoenix Holdings Ltd. 317,138$426,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 255,300$355,0000.01%
ETF MANAGERS GROUP, LLC 157,933$226,0000.01%
View complete list of ONCOCYTE CORP shareholders